Piriformis Syndrome Market Size, Share By 2027 | Technology Development, Global Industry Analysis, Demand Overview, Insights, Growth, Top Company Profile
Global
Piriformis Syndrome Market Research Report: By Cause (Trauma, Spasms, Others),
Diagnostic Test (MRI, Others), Treatment (Medication, Physical Therapy,
Others), Distribution Channel (Retail Pharmacies, Others), End-User – Global
Forecast Till 2027
Piriformis Syndrome Market Highlights
Piriformis
Syndrome is a rare neuromuscular condition in which the
piriformis muscle, located in the buttock region, spasms and causes hip and
buttock pain. The conservative treatment for piriformis syndrome includes
activity modification, the use of anti-inflammatory drugs, physical therapy, an
injection of local anesthetics or corticosteroids, and botulin neurotoxin
injections, among others.
Major factors such as the
growing occurrence of piriformis syndrome, increasing screening for
neuromuscular conditions, growing success of drug treatment for the syndrome,
and the growing geriatric population are expected to drive the growth of the
global piriformis syndrome market. Additionally, according to the data
published by the National Center for Biotechnology Information (NCBI), in 2015,
the occurrence rate of piriformis syndrome was 6% in patients with sciatica
symptoms.
However, the complications of
the piriformis surgery and lack of awareness about the syndrome in developing
countries may hamper the growth of the market during the assessment period.
Furthermore, challenges in the diagnosis of the piriformis syndrome may hamper
the growth of the market.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/6249
Regional
Analysis
The global piriformis syndrome
market consists of four regions, namely, the Americas, Europe, Asia-Pacific,
and the Middle East and Africa. The North American region holds the major share
of the global piriformis syndrome market, owing to the existing
well-established healthcare system, increasing secondary lifestyle, and
increasing geriatric population. Additionally, a large number of orthopedic
procedures due to greater healthcare penetration in the US and Canada
contributes to the growth of the market. Europe is anticipated to hold the
second largest position in the global piriformis market owing to the growing
government support for research and development activities. Additionally,
Asia-Pacific the piriformis market in Asia-Pacific consists of countries,
namely, China, Japan, the Republic of Korea, India, Australia, and the rest of
Asia-Pacific. The Asia-Pacific region is anticipated to be the fastest growing
region in the market owing to the huge population base and rising healthcare
expenditure. Furthermore, the Middle East and Africa holds the lowest share of
the global market owing to the lack of awareness about the syndrome and poor
economic conditions, especially in the African region.
Segmentation
The global piriformis syndrome
market is segmented on the basis of cause, diagnostic test, treatment,
distribution channel, and end-user.
On the basis of cause, the
market is classified as trauma, spasms, overuse injury, and others.
The piriformis syndrome market
on the basis of diagnostic tests is segmented as Magnetic Resonance Imaging
(MRI), X-ray, Computed Tomography (CT), neurophysiologic testing,
Electromyography (EMG), Beatty Test, FAIR (Flexion, adduction, and Internal
Rotation) test, and others.
On the basis of treatment, the
market is segmented into medication, physical therapy, acupuncture,
prolotherapy, Osteopathic Manipulative Treatment (OMT), surgery, and others.
Medication is further segmented into NSAIDs, piriformis muscle injection, and
others. NSAIDs are further segmented into naproxen, ibuprofen, and others. Further,
the piriformis muscle injection is segmented into Botox injection, steroid
injections, and others.
The global piriformis syndrome
market, by distribution channel, is segmented into E-commerce, retail
pharmacies, and others.
On the basis of end-user, the
global piriformis syndrome market is segmented as hospitals and clinics,
diagnostic centers, and others.
Global Piriformis Syndrome Key
Players
Bayer AG, Novartis AG,
AstraZeneca, Endo Pharmaceuticals, Teva Pharmaceuticals, Omron Healthcare,
Sanofi S.A., DePuy Synthes Companies, Miracle Stretch, LLC, Flex Pharma, Inc.,
Nidd valley medical, SEIRIN Corporation, and others are some prominent players
in this market.
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/piriformis-syndrome-market-6249
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment